Human Reproduction, Vol. 18, No. 12, 2582-2589,
December 2003
© 2003 European Society of Human Reproduction and Embryology
Prostacyclin enhances embryo hatching but not sperm motility
1 Obstetrics and GynecologyDivision of Reproductive Endocrinology and 2 Vascular Biology Research Center and Internal MedicineDivision of Hematology, University of TexasHouston Health Science Center, Houston, TX 77030 and 3 Obstetrical and Gynecological Associates, Houston, TX 77030, USA
4 Present address: Johns Hopkins University, Baltimore, MD 21218, USA
5 Present address: College of St Scholastica, Duluth, MN 55811, USA
6 To whom correspondence should be addressed at: Department of Obstetrics and GynecologyDivision of Reproductive Endocrinology, University of TexasHouston Health Science Center, 6431 Fannin, MSB 3.604, Houston, TX 77030, USA. e-mail: jaou-chen.huang{at}uth.tmc.edu
BACKGROUND: Recently we discovered that the human oviduct synthesizes abundant prostacyclin (PGI2). Gene knock-out studies suggest that PGI2 is essential to endometrial decidualization, but the effects of PGI2 on sperm and embryos have not been reported. METHODS: The effects of PGI2 on human sperm were analysed by a computer-assisted semen analysis system. The effects of PGI2 on mouse embryos were examined based on the rates of complete hatching. The expression of PGI2 receptor (IP) was evaluated by Western blot analysis and immunohistochemistry. The binding of PGI2 to embryos was confirmed by radioligand binding assay. Finally, cAMP levels were assessed in PGI2-challenged embryos. RESULTS: Iloprost (a stable PGI2 analogue) did not affect the motility or the overnight survivability of human sperm. Western blot analysis did not detect IP in the sperm plasma membrane. In contrast, the hatching of mouse embryos was enhanced by iloprost (ED50 6.7 nmol/l). Exposure to iloprost during 8-cell to morulae or morulae to early blastocyst stages was critical to enhanced hatching. This coincided with the developmental stage-specific expression of IP. Although iloprost bound to blastocysts, it did not significantly increase cAMP. CONCLUSION: PGI2 enhanced the hatching of mouse embryos but not the motility of human sperm.
Key words: cAMP/co-culture/prostaglandin
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J.-C. Huang, W.-S. A. Wun, J. S. Goldsby, K. Egan, G. A. FitzGerald, and K. K. Wu Prostacyclin receptor signaling and early embryo development in the mouse Hum. Reprod., November 1, 2007; 22(11): 2851 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Huang, W.-S.A. Wun, J.S. Goldsby, I.C. Wun, D. Noorhasan, and K.K. Wu Stimulation of embryo hatching and implantation by prostacyclin and peroxisome proliferator-activated receptor {delta} activation: implication in IVF Hum. Reprod., March 1, 2007; 22(3): 807 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wanggren, P.G. Lalitkumar, A. Stavreus-Evers, B. Stabi, and K. Gemzell-Danielsson Prostaglandin E2 and F2{alpha} receptors in the human Fallopian tube before and after mifepristone treatment Mol. Hum. Reprod., September 1, 2006; 12(9): 577 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Huang, W.-S.A. Wun, J. S. Goldsby, N. Matijevic-Aleksic, and K. K. Wu Cyclooxygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching Hum. Reprod., December 1, 2004; 19(12): 2900 - 2906. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Huang, J. S. Goldsby, F. Arbab, Z. Melhem, N. Aleksic, and K. K. Wu Oviduct prostacyclin functions as a paracrine factor to augment the development of embryos Hum. Reprod., December 1, 2004; 19(12): 2907 - 2912. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Huang, J.S. Goldsby, and W.-S.A. Wun Prostacyclin enhances the implantation and live birth potentials of mouse embryos Hum. Reprod., August 1, 2004; 19(8): 1856 - 1860. [Abstract] [Full Text] [PDF] |
||||

